Predictors of Heterogeneity in Cognitive Function: APOE-e4, Sex, Education, Depression, and Vascular Risk

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
Rebecca K MacAulayJeffrey N Keller

Abstract

Mild cognitive impairment and dementia are clinically heterogeneous disorders influenced by diverse risk factors. Improved characterization of the effect of multiple risk factors influence on specific cognitive functions may improve understanding of mechanisms in early cognitive change and lead to more effective interventions. Structural equation modeling (SEM) simultaneously examined the effects of modifiable (education, depression, and metabolic/vascular risk) and nonmodifiable risk factors (age, sex, and apolipoprotein E-ɛ4 allele [APOE-e4] status) on specific cognitive domains in 461 cognitively normal older adults. The hypothesized model(s) provided an adequate fit for the data. Sex differences in cognition, depression, and vascular risk were found. On average, men were higher in vascular risk with generally lower cognitive performance than women; women were more likely to have depression. APOE-e4 associated with depression but not age, sex, or metabolic/vascular risk. Depression associated with lower executive attention, memory, and language performance, whereas metabolic/vascular risk associated with lower executive attention, memory, and working memory. Older age and lower education are associated with worse performance...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Apr 10, 2002·Journal of the International Neuropsychological Society : JINS·Yaakov Stern
Jun 16, 2004·Alzheimer Disease and Associated Disorders·Ronald C Petersen
Dec 9, 2004·Psychology and Aging·Brent J SmallLars Bäckman
Nov 30, 2006·Alzheimer Disease and Associated Disorders·John C MorrisWalter A Kukull
Feb 20, 2008·Journal of the International Neuropsychological Society : JINS·Diane B HowiesonJeffrey A Kaye
Mar 19, 2008·Neuropsychology Review·Mark W BondiDavid P Salmon
Jul 9, 2008·The Clinical Neuropsychologist·Katheen A Welsh-BohmerUNKNOWN Cache Country Study Group
Feb 3, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Mathew NitiTze-Pin Ng
May 29, 2009·Alzheimer Disease and Associated Disorders·Sandra WeintraubJohn C Morris
Jul 17, 2009·The New England Journal of Medicine·Richard J CaselliEric M Reiman
Feb 23, 2010·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Andrew GrabovichJeffrey M Lyness
Jul 22, 2011·Lancet Neurology·Deborah E Barnes, Kristine Yaffe
Jul 23, 2011·Stroke; a Journal of Cerebral Circulation·Philip B GorelickUNKNOWN American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Counci
Sep 20, 2011·Journal of the International Neuropsychological Society : JINS·Laura B ZahodneJennifer J Manly
May 9, 2012·Brain Imaging and Behavior·Julene K JohnsonUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Dec 19, 2012·Journal of Alzheimer's Disease : JAD·Liang FengTze Pin Ng
Feb 1, 2013·Neuroepidemiology·L L BarnesD A Bennett
Apr 23, 2013·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Katherine J BangenRhoda Au
Feb 5, 2014·Journal of the International Neuropsychological Society : JINS·Mark W Bondi, Glenn E Smith
Mar 14, 2014·Annals of Neurology·Andre AltmannUNKNOWN Alzheimer's Disease Neuroimaging Initiative Investigators
Apr 1, 2014·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·R Scott MackinPatricia A Arean
Dec 3, 2014·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Mark B SnowdenAnnette L Fitzpatrick
Jun 3, 2015·Psychosomatic Medicine·Michelle LucianoUNKNOWN Generation Scotland Investigators
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Emily C EdmondsUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jan 9, 2016·Journal of Affective Disorders·Katherine L MuslinerPeter P Zandi
Oct 25, 2016·Ageing Research Reviews·Bonnie AuMary C Tierney
May 31, 2017·Translational Psychiatry·I K KarlssonS Hägg
Jun 6, 2017·Journal of the International Neuropsychological Society : JINS·Joel S EppigUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jul 4, 2017·Journal of Clinical and Experimental Neuropsychology·Rebecca K MacAulayJeffrey N Keller

❮ Previous
Next ❯

Citations

Apr 17, 2020·International Journal of Environmental Research and Public Health·Hong LuoLiping Yu
Dec 31, 2020·Antioxidants·Cadiele Oliana ReichertSergio P Bydlowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

© 2021 Meta ULC. All rights reserved